Pavani Kaki
Research Subjects
Pavani Kaki has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Harinadha Baba Kudipudi
Department of Pharmaceutical Analysis, Narayana Pharmacy College, Nellore 524004, India
1 shared publication - Mary Stella Gurajapu
Department of Pharm.D Narayana Pharmacy College, Nellore 524004, India
1 shared publication - Monapati Suchitra
Ratnam Institute of Pharmacy, Nellore, India
1 shared publication - Prathibha Guttal Subhas
Department of Pharmacognosy, Bapuji Pharmacy College, Davanagere 577004, India
1 shared publication
Latest Publications
- Open Access
- 28 November 2023
- Published by MDPI AG in Drugs and Drug Candidates
- Vol. 2 (4) , 923-936
The Effects of Vitamin D on Preventing Hyperglycemia and a Novel Approach to Its Treatment
The dietary reference levels for vitamin D were established with an emphasis on its role in bone health; however, with the identification of vitamin D receptors in all body tissues novel associations with other metabolic disorders, such as diabetes, are being researched. Aside from its standard function as the main regulator of calcium absorption, vitamin D also controls the calcium pool, mediates the activity of beta cell calcium-dependent endopeptidases, encourages the conversion of proinsulin to insulin, increases insulin output, and raises insulin activity in peripheral insulin target tissues. Both immune cells and pancreatic beta cells include vitamin D receptors. A deficiency of vitamin D causes glucose intolerance and affects insulin secretion. Different pathogenic characteristics of the disease are linked to a number of vitamin D-related genes. It has been proven that vitamin D supplementation lowers the risk of type 1 and type 2 diabetes and its associated problems. In this article, we discussed a few prospective clinical trials on vitamin D that are necessary to clearly demonstrate the role of vitamin D in the prevention and management of diabetes.
- 28 November 2023
- Published by MDPI AG in Drugs and Drug Candidates
- Vol. 2 (4) , 923-936
Open AccessThe Effects of Vitamin D on Preventing Hyperglycemia and a Novel Approach to Its Treatment
The dietary reference levels for vitamin D were established with an emphasis on its role in bone health; however, with the identification of vitamin D receptors in all body tissues novel associations with other metabolic disorders, such as diabetes, are being researched. Aside from its standard function as the main regulator of calcium absorption, vitamin D also controls the calcium pool, mediates the activity of beta cell calcium-dependent endopeptidases, encourages the conversion of proinsulin to insulin, increases insulin output, and raises insulin activity in peripheral insulin target tissues. Both immune cells and pancreatic beta cells include vitamin D receptors. A deficiency of vitamin D causes glucose intolerance and affects insulin secretion. Different pathogenic characteristics of the disease are linked to a number of vitamin D-related genes. It has been proven that vitamin D supplementation lowers the risk of type 1 and type 2 diabetes and its associated problems. In this article, we discussed a few prospective clinical trials on vitamin D that are necessary to clearly demonstrate the role of vitamin D in the prevention and management of diabetes.